This page has been archived on the Web

Information identified as archived is provided for reference, research or recordkeeping purposes. It is not subject to the Government of Canada Web Standards and has not been altered or updated since it was archived. Please contact us to request a format other than those available.

Health product recall

Recall of Paxil Products (2014-04-08)

Starting date:
April 8, 2014
Posting date:
May 1, 2014
Type of communication:
Drug Recall
Subcategory:
Drugs
Hazard classification:
Type III
Source of recall:
Health Canada
Issue:
Product Safety
Audience:
General Public, Healthcare Professionals, Hospitals
Identification number:
RA-39059

Recalled Products

A. Paxil CR 25 mg

B. Paxil CR 12.5 mg

C. Paxil Tablets 20 mg

D. Paxil Tablets 10 mg

Reason

The industrial methylated spirits used to manufacture paroxetine drug substance were contaminated with material from the pharmaceutical waste tank which contained various other APIs, intermediates and solvents. GSK is recalling all tablet lots which were manufactured with the contaminated paroxetine drug substance batches.

Depth of distribution

Wholesalers across Canada

Affected products

A. Paxil CR 25 mg

DIN, NPN, DIN-HIM

DIN 02248504

Dosage form

Controlled-Release Tablets

Strength

25 mg

Lot or serial number
  • 2A001
  • 2C002
  • 2E003
  • 2F005
  • 2F004
  • 2H006
Companies
Recalling Firm

GlaxoSmithKline Inc.

7333 Mississauga Road North

Mississauga

L5N 6L4

Ontario

CANADA

Marketing Authorization Holder

GlaxoSmithKline Inc.

7333 Mississauga Road North

Mississauga

L5N 6L4

Ontario

CANADA



B. Paxil CR 12.5 mg

DIN, NPN, DIN-HIM

DIN 02248503

Dosage form

Controlled-Release Tablets

Strength

12.5 mg

Lot or serial number
  • 2A001
  • 2B003
  • 2E002
Companies
Recalling Firm

GlaxoSmithKline Inc.

7333 Mississauga Road North

Mississauga

L5N 6L4

Ontario

CANADA

Marketing Authorization Holder

GlaxoSmithKline Inc.

7333 Mississauga Road North

Mississauga

L5N 6L4

Ontario

CANADA



C. Paxil Tablets 20 mg

DIN, NPN, DIN-HIM

DIN 01940481

Dosage form

Tablets

Strength

20 mg

Lot or serial number
  • 2ZP2644
  • 2ZP5500
Companies
Recalling Firm

GlaxoSmithKline Inc.

7333 Mississauga Road North

Mississauga

L5N 6L4

Ontario

CANADA

Marketing Authorization Holder

GlaxoSmithKline Inc.

7333 Mississauga Road North

Mississauga

L5N 6L4

Ontario

CANADA



D. Paxil Tablets 10 mg

DIN, NPN, DIN-HIM

DIN 02027887

Dosage form

Tablets

Strength

10 mg

Lot or serial number
  • 2ZP0326
  • 3ZP4587
Companies
Recalling Firm

GlaxoSmithKline Inc.

7333 Mississauga Road North

Mississauga

L5N 6L4

Ontario

CANADA

Marketing Authorization Holder

GlaxoSmithKline Inc.

7333 Mississauga Road North

Mississauga

L5N 6L4

Ontario

CANADA